rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1998-4-23
|
pubmed:abstractText |
Our present study provides evidence that the 4-1BB signal is critical to CD28 co-stimulation in maintaining T cell activation when CD28 has been down-regulated because of repeated stimulation. The 4-1BB signal synergized with CD28 co-stimulation by lowering the threshold of anti-CD28 required to sustain proliferation and IL-2 production. The 4-1BB signal also modulated CD28-mediated cytokine profiles by markedly enhancing Th1 but suppressing Th2-type cytokine production. The 4-1BB signal generated Th1-type cells, as identified by intracellular IFN-gamma production. IFN-gamma induction was detected preferentially in 4-1BB-expressing cells, but not in those expressing CD30. 4-1BB and CD30 were induced in both CD4+ and CD8+ cells, but the location of the two molecules was mutually exclusive in each T cell subset. Our study suggests that the 4-1BB signal regulates CD28 co-stimulation in the targeted subset cells to favor Th1 development and maintain long-term cell growth.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD137,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD28,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD30,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Nerve Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF9 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2980
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
881-90
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9541583-Antigens, CD,
pubmed-meshheading:9541583-Antigens, CD137,
pubmed-meshheading:9541583-Antigens, CD28,
pubmed-meshheading:9541583-Antigens, CD30,
pubmed-meshheading:9541583-Cell Division,
pubmed-meshheading:9541583-Cytokines,
pubmed-meshheading:9541583-Humans,
pubmed-meshheading:9541583-Interferon-gamma,
pubmed-meshheading:9541583-Interleukin-4,
pubmed-meshheading:9541583-Lymphocyte Activation,
pubmed-meshheading:9541583-Receptors, Nerve Growth Factor,
pubmed-meshheading:9541583-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:9541583-S Phase,
pubmed-meshheading:9541583-Signal Transduction,
pubmed-meshheading:9541583-T-Lymphocyte Subsets,
pubmed-meshheading:9541583-Th1 Cells
|
pubmed:year |
1998
|
pubmed:articleTitle |
Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|